Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Phase II study of gevokizumab in patients with diabetic nephropathy begins

April 2, 2015

Cortendo report new cytochrome P450 inhibtors

April 2, 2015

Cerdelga approved for Gaucher's disease in Japan

April 1, 2015

Sichuan Haisco Pharmaceutical patents FFAR1 agonists

March 31, 2015

CHMP recommends approval of empagliflozin/metformin for type 2 diabetes

March 31, 2015

AG-348 assigned orphan status for pyruvate kinase deficiency

March 30, 2015

Novel GPBAR1 agonists synthesized for the treatment of diabetes and metabolic syndrome

March 30, 2015

European Commission approves Mysimba for weight management

March 27, 2015

Trelagliptin gains first approval in Japan

March 27, 2015

MBX-8025 gains U.S. orphan drug status for homozygous familial hypercholesterolemia

March 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026